IMS MAXIMS Celebrates Major New Investment

IMS MAXIMSLeading healthcare IT supplier IMS MAXIMS has announced a major new investor, laying the foundations for future growth. Thomas Anderson, who has taken full ownership of the company, and CEO Shane Tickell, have now outlined their ambitions to build IMS MAXIMS into a substantial force in international healthcare IT.

Mr Anderson is best known for being the principal of the Empire Cinema Group. He also has a keen interest in both the IT and healthcare industries and this acquisition allows him to combine these.

Mr Anderson said: "IMS MAXIMS has proven software which enables clinicians in the UK and Ireland to deliver the best possible healthcare services to millions of patients.

"I have a passionate belief in Irish business and am convinced that IMS MAXIMS has the products, the vision, and the leadership to make a truly significant contribution to improving healthcare in Ireland, the UK, Europe and beyond. I look forward to working with Shane and his team in the years ahead and to IMS MAXIMS going from strength to strength."

The news was announced at a hearing of the High Court in Dublin during which the company was declared to be financially sound and was released from a form of temporary protection, known as Examinership. IMS MAXIMS, which is headquartered in Dublin, was accepted into Examinership in August after its former parent company ran into difficulties. This provided the opportunity to find an investor to recapitalise and ensure the growth of the business.

Shane Tickell said: "Thanks to this new investment we are better placed than ever for growth and success. It's excellent news for IMS MAXIMS and its customers that we have secured the backing of someone with Thomas Anderson's business skills and commitment to Irish enterprise. He has a clear appreciation of the quality of our existing products and of the excellence of our R&D, which will allow us to expand by offering new advanced software solutions to clients in the public and independent sectors, at home and overseas.

"We conducted business as usual throughout the Examinership, which demonstrates the high levels of confidence our customers have in IMS MAXIMS and its products. In the last few weeks we have even announced a new series of options which give customers even more choice over how they access our clinical and administrative software. In the coming months we will make further announcements, underlining that this is a vibrant and energetic business with a huge amount to offer the world of healthcare."

Mr Anderson's investment will provide IMS MAXIMS with the necessary resources for further product improvements and reduced delivery times. The company will now be able to develop its medium and long-term strategy to expand its portfolio of products and services and establish a global presence.

About IMS MAXIMS
IMS MAXIMS is the company behind the widely-used MAXIMS clinical PAS. It is a specialist in developing clinical and administrative software solutions and currently supports more than 150 organisations, 1.9 million patient records in Ireland and 8 million patient records in the UK, as well as 10,000 users of IMS MAXIMS products.

About the MAXIMS clinical PAS
MAXIMS gives clinicians the applications they need to provide the best possible patient care, and allows provider organisations to manage their patient administration with ease and efficiency. Rival products often tend to be administrative systems with clinical software added on. MAXIMS is equally focused on the needs of clinicians and provider organisations - which we believe is the way to guarantee the best patient outcomes with optimum efficiency.

MAXIMS is at the heart of the clinical and administrative life of everything from large UK and Irish hospitals, to small specialist independent clinics. It gives patient data to clinicians in exactly the format they need, and allows it to be shared with colleagues and updated in real-time. MAXIMS suits any clinical specialism and is excellent for order communications and reporting. Medical and administrative records can be kept fully up to date, with the minimum of effort. MAXIMS is web-based so there is no need to install software on computers or invest in expensive extra hardware.

Most Popular Now

Research Shows AI Technology Improves Pa…

Existing research indicates that the accuracy of a Parkinson's disease diagnosis hovers between 55% and 78% in the first five years of assessment. That's partly because Parkinson's sibling movement disorders...

AI in Healthcare: How do We Get from Hyp…

The Highland Marketing advisory board met to consider the government's enthusiasm for AI. To date, healthcare has mostly experimented with decision support tools, and their impact on the NHS and...

Who's to Blame When AI Makes a Medi…

Assistive artificial intelligence technologies hold significant promise for transforming health care by aiding physicians in diagnosing, managing, and treating patients. However, the current trend of assistive AI implementation could actually...

First Therapy Chatbot Trial Shows AI can…

Dartmouth researchers conducted the first clinical trial of a therapy chatbot powered by generative AI and found that the software resulted in significant improvements in participants' symptoms, according to results...

DMEA sparks: The Future of Digital Healt…

8 - 10 April 2025, Berlin, Germany. Digitalization is considered one of the key strategies for addressing the shortage of skilled workers - but the digital health sector also needs qualified...

DeepSeek: The "Watson" to Doct…

DeepSeek is an artificial intelligence (AI) platform built on deep learning and natural language processing (NLP) technologies. Its core products include the DeepSeek-R1 and DeepSeek-V3 models. Leveraging an efficient Mixture...

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...